Why the study?
Does the UCSF-CAPRA score accurately predict biochemical recurrence after radical prostatectomy in a diverse cohort?
Does the UCSF-CAPRA score accurately predict biochemical recurrence after radical prostatectomy in a diverse cohort?
The UCSF-CAPRA score is a valid and accurate tool for predicting biochemical recurrence and adverse pathologic outcomes after radical prostatectomy in a diverse patient population.
No takes yet. Share an insight, caveat, or question.
Supports CAPRA for recurrence risk stratification in diverse post-prostatectomy patients; extends prior validations but leaves adoption questions open.
Cooperberg et al. (2006) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: